Accordingly, TRIM25 is overexpressed in many human cancers and a high tissue expression level of TRIM25 often correlates with an unfavorable prognosis and outcome of patients, thus highlighting the potential of TRIM25 as a biomarker and a valid therapeutic target for novel anticancer therapies. The gene discussed is TRIM25; the disease is cancer.